After a few more appointments and tests, it was discovered he was at 5% kidney function and diagnosed with IgA nephropathy, also known as Berger's disease, which is a chronic kidney disease ...

and baseline disease characteristics, as well as in the exploratory SGLT2i cohort. “Today’s approval marks an important milestone for people living with IgA nephropathy, offering a new option that can ...

IgA Nephropathy Foundation. "The approval of Vanrafia broadens the treatment landscape and expands the opportunity to tailor care in a disease that can impact each patient so differently." In the ...

3. Explain the management of IgAN standard and novel targeted therapies. 4. Discuss the long-term outcomes of IgA nephropathy, such as the risk of progressive kidney disease and end-stage renal ...

Novartis’ Vanrafia (atrasentan) has been granted accelerated approval by the US Food and Drug Administration (FDA) to treat patients with the rare kidney disease immunoglobulin A nephropathy ...

to treat primary immunoglobulin A nephropathy (IgAN), also known as Berger’s disease. Vanrafia is a once-daily, non-steroidal, oral treatment that can be added onto supportive care, including a ...

IgA Nephropathy Foundation. "The approval of Vanrafia broadens the treatment landscape and expands the opportunity to tailor care in a disease that can impact each patient so differently." ...

IgA Nephropathy Foundation. "The approval of Vanrafia broadens the treatment landscape and expands the opportunity to tailor care in a disease that can impact each patient so differently." ...

The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary immunoglobulin A (IgA ... also known as Berger's disease, progress to kidney ...

Primary IgA nephropathy is a disease where IgA protein builds up in the kidneys, damaging them. 2 The condition can be diagnosed through urine tests, where elevated protein may be found.

Edgar Lerma, MD, provides insights into the pathophysiology of IgA nephropathy (IgAN) and the therapeutic promise ... treatment landscape for this significant cause of chronic kidney disease. Dr.

IgA nephropathy (IgAN), also called Berger's disease, is a rare progressive kidney disease characterized by the buildup of immunoglobulin A (IgA), a protein that helps the body fight infections ...